| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $166.7M | +4.8% | -11.8% |
| Cost of Revenue | $130.5M | +3.9% | -8.3% |
| R&D Expense | $400K | +0.0% | +0.0% |
| SG&A Expense | $15.6M | -13.3% | -26.4% |
| Operating Income | -$3.0M | +65.5% | -372.7% |
| Interest Expense | $11.1M | +0.9% | +13.3% |
| Pre-tax Income | -$14.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.3M | -50.3% | -90.0% |
| Accounts Receivable | $110.6M | +4.3% | -11.4% |
| Inventory | $32.7M | +2.2% | +0.0% |
| Current Assets | $164.2M | -4.9% | -35.6% |
| Total Assets | $358.2M | -3.1% | -26.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | — |
| Capital Expenditures | $12.0M | -5.5% | -42.9% |
| Investing Cash Flow | -$29.1M | — | — |
| Financing Cash Flow | -$49.1M | — | — |
| Free Cash Flow | -$17.0M | — | — |
| +28.4% |
| -76.3% |
| Income Tax | $200K | +0.0% | +0.0% |
| Net Income | -$14.3M | +28.1% | -74.4% |
| EPS (Basic) | -$0.74 | +28.8% | -45.1% |
| EPS (Diluted) | -$0.74 | +28.8% | -45.1% |
| $137.2M |
| -1.4% |
| -33.1% |
| Long-term Debt | $259.2M | +0.2% | -9.1% |
| Stockholders' Equity | -$61.2M | -29.7% | -2548.0% |